As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
Novartis joins seven global companies to found the Value Balancing Alliance
Novartis announced the company’s financial results for the second quarter and first half of 2019.
Novartis transforms its Global Health & Corporate Responsibility organization.
For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.